The market continued to decline, listed companies were in a hurry, and investor confidence was also hit. What should I do? To eliminate panic through communication and strengthen confidence through research, active institutional investors took action to intensively “seek medical advice” from listed companies, hoping to obtain “reassurance” in advance.
On March 15, more than a dozen listed companies intensively disclosed the Institutional Research Report of that day. In the face of a series of questions from investors about the company’s operating performance, capacity planning and future development, the core executives of listed companies answered questions patiently. Report performance, talk about production capacity, talk about prosperity, talk about the future… Sincere and firm answers may gradually calm investors’ anxiety.
Affected by the epidemic, many institutional investors are unable to go to the company for field research, and Internet telephony has become a “bridge” to connect confidence at both ends Namchow Food Group(Shanghai) Co.Ltd(605339) , Shanghai M&G Stationery Inc(603899) , Chengtun Mining Group Co.Ltd(600711) and other companies widely accept investors’ questions in the form of teleconference. Among them, Namchow Food Group(Shanghai) Co.Ltd(605339) is the most popular, with 4 teleconferences a day and more than 120 institutional investors.
4 calls in 1 days will attract more than 120 institutions
On March 15, Namchow Food Group(Shanghai) Co.Ltd(605339) released its annual report for 2021. Last year, the company achieved an operating revenue of 2.873 billion yuan, an increase of 23.71% year-on-year; The net profit was 368 million yuan, a year-on-year increase of 13.27%. On the same day, institutional investors pinched some research, asked in detail and explored the highlights of the company’s annual report.
From 9:30 a.m. to 4:00 p.m. yesterday, Namchow Food Group(Shanghai) Co.Ltd(605339) held four consecutive teleconferences and received more than 120 institutional investors, including Tianfeng Securities Co.Ltd(601162) , Guotai Junan Securities Co.Ltd(601211) , Northeast Securities Co.Ltd(000686) , Zheshang Securities Co.Ltd(601878) , Morgan Stanley Huaxin Fund, Boshi fund, Shanghai Investment Morgan fund and Wells Fargo fund.
The capacity expansion plan is the focus of investors’ questioning Namchow Food Group(Shanghai) Co.Ltd(605339) general manager Lin Changyu shared the latest production plan. He said that on January 6, 2022, Shanghai Nanqiao phase II frozen dough project was officially put into operation, becoming the second frozen dough production base after Tianjin factory. The second production line of Shanghai Nanqiao phase II frozen dough project is planned to be put into operation in July 2022. The annual production capacity of Shanghai Nanqiao phase II frozen dough project is expected to reach 473688 tons. “At present, the company is orderly promoting the construction of relevant production bases and production lines in accordance with the fund-raising and investment plan. In the future, the company will continue to expand production capacity based on the current production capacity according to the market situation, meet the market demand and further improve the market share.” Lin Changyu said.
With the production line put into operation, how about the expansion of new customers? Lin Changyu revealed that at present, the company’s marketing team is actively communicating with a number of boutique supermarkets to seek cooperation opportunities. In the future, the company will continue to be market-oriented and rely on the existing marketing model to continuously develop new customers.
not afraid of the epidemic, accelerate production expansion and steady growth
“Epidemic problem” has also become a common hot topic for institutional investors. However, listed companies from all walks of life seem to send a positive signal.
In combination with the company’s performance express, Shanghai M&G Stationery Inc(603899) Secretary Quan Qiang shared the impact of the epidemic on future development. Quan Qiang said that in 2022, the company’s new business is expected to continue to maintain rapid growth, and the traditional core business will maintain a medium-term growth target of 10% to 15%. “The reason why we are confident to maintain the medium-term growth target of 10% to 15% of our traditional core business is that the trend of consumption upgrading in China is still established, and the company has strong competitive advantages in products, channels and teams.” After adjustment, the performance of Jiumu sundry agency is obviously better than the change of passenger flow in shopping malls and business districts. In 2022, it is planned to maintain more than 100 stores.
Chengtun Mining Group Co.Ltd(600711) president Zhang Zhenpeng responded to investors’ concerns about the progress of overseas projects. Zhang Zhenpeng said that the company’s CCM project in the Democratic Republic of the Congo has been completed and put into operation, and is currently in the stage of capacity climbing; The kalonway project is progressing smoothly and is expected to be completed and put into operation by the end of 2022 as planned without delay. With the implementation of the above two projects, the company expects the output of copper to be 60000 tons to 65000 tons and the output of cobalt to be 9000 tons to 10000 tons in 2022; In 2023, the output of copper is expected to be 100000 tons and the output of cobalt is expected to be 13000 to 15000 tons. “The epidemic has not had a material impact on the company’s production and operation, and the company’s strategic objectives are being implemented one by one according to the established plan.” He said.
More than a dozen institutions such as Harvest Fund, Jingshun Great Wall Fund and Gaoyi assets entered Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) , and had a warm interaction with the company’s executives. The performance express shows that in Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) 2021, the sales revenue reached 5.75 billion yuan, an increase of 144%; The net profit exceeded 2 billion yuan, an increase of nearly 2 times.
Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) chief financial officer Zhao Yiyong said: “the company’s bivalent HPV vaccine continues to maintain prosperous production and sales, with rapid growth in revenue and profit. The vaccine sales exceed 10 million and the revenue exceeds 3 billion yuan. Due to the significant increase in overseas testing demand, the company’s covid-19 raw material sales and overseas testing reagent export revenue have achieved rapid growth.” It is reported that the company’s existing design capacity of nine valent HPV can reach 20 million pieces / year. After the completion of the phase II expansion construction project of nine valent cervical cancer vaccine, the design capacity of nine valent HPV vaccine can be increased to 60 million pieces / year.
basically oriented to good faith and firm in seeking a new situation
The capital market is not only an information market, but also a confidence market. In view of the recent market downturn, a number of listed companies were interviewed by reporters to convey their confidence and confidence.
In March this year, China United Network Communications Limited(600050) completed a one-year repurchase program for a shares, and spent a total of 2.2 billion yuan to repurchase 500 million shares China United Network Communications Limited(600050) relevant person in charge said that recently, affected by the market environment, the company’s share price did fluctuate, but the firm fundamentals of the company did not change due to market sentiment. “We always believe that good business development is the basis for the company’s long-term value promotion, and the stock price will eventually return to the company’s value. In the future, the company will make unremitting efforts to continuously promote the good growth of fundamentals and continuously improve the enterprise value.”
Let’s look at the performance of China Mobile, which has landed in A-Shares for only more than two months. As of the closing on March 15, China Mobile’s A-share Pb was 1.06, PE was 11.15, Hong Kong share Pb was 0.73 and PE was 7.34, which were significantly lower than the average value of international operator leading Pb and PE (the average value of international operator leading Pb was 1.45 and the average value of PE excluding loss making companies was 41.16). The company’s valuation is at a relatively low level. In fact, in 2021, the company achieved all-round improvement in customer value, enterprise value and shareholder value, with excellent business performance. From January to February 2022, the main business indicators also performed well.
Based on China Mobile’s long-term development plan and its strong confidence in the future, China Mobile’s investment in A-share is worthy of China Mobile’s strong recognition. The planned period of shareholding increase is from January 21, 2022 to December 31, 2022. The planned amount of shareholding increase is 3 billion yuan to 5 billion yuan, and there is no share purchase price range. China Mobile Group has increased its holdings of about 26.21 million A-Shares of the company on January 27, with a cumulative increase of about 1.509 billion yuan.
China Mobile has always attached importance to interaction and communication with investors. On January 21, the company took the initiative to hold an A-share analyst exchange meeting, carried out online exchanges with 36 analysts from 23 securities companies, and actively introduced the highlights of the company’s operation and development and the transformation and development strategies and measures for the new blue ocean of digital economy to the market.
Wingtech Technology Co.Ltd(600745) relevant person in charge admitted to the reporter: “the market sentiment has indeed caused a certain impact on the stock market and brought tension to investors. However, in terms of enterprise operation, the company has been unswervingly promoting its business around the company’s established strategy. At present, the company’s R & D, production and business activities are normal and have not been affected by the sentiment of the capital market.”
Referring to the business highlights in 2022, Wingtech Technology Co.Ltd(600745) said that the company will take semiconductors as the leader, increase investment, improve innovation ability, enable component and system integration, comprehensively improve the core competitiveness of complete machine products, and promote the strategic transformation of Wingtech Technology Co.Ltd(600745) from a service-oriented company to a product company.
